Oral mucositis in patients with antineoplastic therapy
Oral mucositis is one of the most common and symptomatic complications of antineoplasic therapy and is associated with a significant increase in morbidity, pain, functional limitation, deterioration in quality of life and overall costs of medical care. The incidence of mucosal inflammation (mucositi...
Saved in:
| Published in | Medicina U.P.B Vol. 29; no. 2 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English Spanish |
| Published |
Medellín
Universidad Pontificia Bolivariana
01.07.2010
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | Oral mucositis is one of the most common and symptomatic complications of antineoplasic therapy and is associated with a significant increase in morbidity, pain, functional limitation, deterioration in quality of life and overall costs of medical care. The incidence of mucosal inflammation (mucositis) in patients with head and neck cancer undergoing radiotherapy may be as high as 100%, those receiving chemotherapy present mucositis in up to 4070% depending on the scheme allocated. Multiple strategies have been studied for both prevention and the management of oral mucositis, but the results are not consistent and many of the existing interventions are used in an empirical way, without scientific evidence that supports whether its use should be continued or not. |
|---|---|
| ISSN: | 0120-4874 2357-6308 |